Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP) jurisdictions

被引:19
|
作者
Eden, Michael [1 ]
Harrison, Samantha [2 ]
Griffin, Michelle [3 ]
Lambe, Mats [4 ]
Pettersson, David [5 ]
Gavin, Anna [6 ]
Brewster, David H. [7 ]
Lin, Yulan [8 ]
Johannesen, Tom B. [9 ]
Milne, Roger L. [10 ]
Farrugia, Helen [11 ]
Nishri, Diane [12 ]
King, Mary-Jane [13 ]
Huws, Dyfed W. [14 ]
Warlow, Janet [14 ]
Turner, Donna [15 ]
Earle, Craig C. [16 ]
Peake, Michael [1 ,17 ]
Rashbass, Jem [3 ]
机构
[1] NCRAS, London, England
[2] Canc Res UK, Policy & Informat, Oakham, England
[3] Publ Hlth England, Natl Dis Registrat, London, England
[4] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden
[5] Natl Board Hlth & Welf, Stockholm, Sweden
[6] Queens Univ Belfast, N Ireland Canc Registry, Belfast, Antrim, North Ireland
[7] NHS Natl Serv Scotland, Scottish Canc Registry, Edinburgh, Midlothian, Scotland
[8] Norwegian Univ Sci & Technol NTNU, European Palliat Care Res Ctr PRC, Dept Clin & Mol Med, Trondheim, Norway
[9] Canc Registry Norway, Oslo, Norway
[10] Canc Council Victoria, Canc Epidemiol & Intelligence Div, Melbourne, Vic, Australia
[11] Canc Council Victoria, Victorian Canc Registry, Melbourne, Vic, Australia
[12] Canc Care Ontario, Prevent & Canc Control, Toronto, ON, Canada
[13] Canc Care Ontario, Ontario Canc Registry, Toronto, ON, Canada
[14] Publ Hlth Wales, Welsh Canc Intelligence & Surveillance Unit, Cardiff, S Glam, Wales
[15] CancerCare Manitoba, Epidemiol & Canc Registry, Winnipeg, MB, Canada
[16] Ontario Inst Canc Res, Inst Clin Evaluat Sci, Toronto, ON, Canada
[17] Univ Leicester, Resp Med, Leicester, Leics, England
关键词
Cancer survival; Cancer registration; Date of diagnosis; Death certificate; Multiple primaries; International comparisons; DEATH CERTIFICATE; COMPLETENESS; DIAGNOSIS; PATIENT; 1ST;
D O I
10.1016/j.canep.2018.10.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: International cancer survival comparisons use cancer registration data to report cancer survival, which informs the development of cancer policy and practice. Studies like the International Cancer Benchmarking Partnership (ICBP) have a duty to understand how registration differences impact on survival prior to drawing conclusions. Methods: Key informants reported differences in registration practice for capturing incidence date, death certificate case handling and registration of multiple primary tumours. Sensitivity analyses estimated their impact on one-year survival using baseline and supplementary cancer registration data from England and Sweden. Results: Variations in registration practice accounted for up to a 7.3 percentage point difference between unadjusted (estimates from previous ICBP survival data) and adjusted (estimates recalculated accounting for registration differences) one-year survival, depending on tumour site and jurisdiction. One-year survival estimates for four jurisdictions were affected by adjustment: New South Wales, Norway, Ontario, Sweden. Sweden and Ontario's survival reduced after adjustment, yet they remained the jurisdictions with the highest survival for breast and ovarian cancer respectively. Sweden had the highest unadjusted lung cancer survival of 43.6% which was adjusted to 39.0% leaving Victoria and Manitoba with the highest estimate at 42.7%. For colorectal cancer, Victoria's highest survival of 85.1% remained unchanged after adjustment. Conclusion: Population-based cancer survival comparisons can be subject to registration biases that may impact the reported 'survival gap' between populations. Efforts should be made to apply consistent registration practices internationally. In the meantime, survival comparison studies should provide acknowledgement of or adjustment for the registration biases that may affect their conclusions.
引用
收藏
页码:184 / 192
页数:9
相关论文
共 50 条
  • [1] Diagnostic routes and time intervals for ovarian cancer in nine international jurisdictions; findings from the International Cancer Benchmarking Partnership (ICBP)
    Usha Menon
    David Weller
    Alina Zalounina Falborg
    Henry Jensen
    John Butler
    Andriana Barisic
    Anne Kari Knudsen
    Rebecca J. Bergin
    David H. Brewster
    Victoria Cairnduff
    Evangelia Ourania Fourkala
    Anna T. Gavin
    Eva Grunfeld
    Elizabeth Harland
    Jatinderpal Kalsi
    Rebecca-Jane Law
    Yulan Lin
    Donna Turner
    Richard D. Neal
    Victoria White
    Samantha Harrison
    Irene Reguilon
    Charlotte Lynch
    Peter Vedsted
    British Journal of Cancer, 2022, 127 : 844 - 854
  • [2] Diagnostic Routes and Time Intervals for Ovarian Cancer in Nine International Jurisdictions; Findings From the International Cancer Benchmarking Partnership (ICBP)
    Menon, Usha
    Weller, David
    Falborg, Alina Zalounina
    Jensen, Henry
    Butler, John
    Barisic, Andriana
    Knudsen, Anne Kari
    Bergin, Rebecca J.
    Brewster, David H.
    Cairnduff, Victoria
    Fourkala, Evangelia Ourania
    Gavin, Anna T.
    Grunfeld, Eva
    Harland, Elizabeth
    Kalsi, Jatinderpal
    Law, Rebecca-Jane
    Lin, Yulan
    Turner, Donna
    Neal, Richard D.
    White, Victoria
    Harrison, Samantha
    Reguilon, Irene
    Lynch, Charlotte
    Vedsted, Peter
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2022, 77 (12) : 739 - 740
  • [3] Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey
    Rose, Peter W.
    Rubin, Greg
    Perera-Salazar, Rafael
    Almberg, Sigrun Saur
    Barisic, Andriana
    Dawes, Martin
    Grunfeld, Eva
    Hart, Nigel
    Nea, Richard D.
    Pirotta, Marie
    Sisler, Jeffrey
    Konrad, Gerald
    Toftegaard, Berit Skjodeberg
    Thulesius, Hans
    Vedsted, Peter
    Young, Jane
    Hamilton, Willie
    BMJ OPEN, 2015, 5 (05):
  • [4] Diagnostic routes and time intervals for ovarian cancer in nine international jurisdictions; findings from the International Cancer Benchmarking Partnership (ICBP)
    Menon, Usha
    Weller, David
    Falborg, Alina Zalounina
    Jensen, Henry
    Butler, John
    Barisic, Andriana
    Knudsen, Anne Kari
    Bergin, Rebecca J.
    Brewster, David H.
    Cairnduff, Victoria
    Fourkala, Evangelia Ourania
    Gavin, Anna T.
    Grunfeld, Eva
    Harland, Elizabeth
    Kalsi, Jatinderpal
    Law, Rebecca-Jane
    Lin, Yulan
    Turner, Donna
    Neal, Richard D.
    White, Victoria
    Harrison, Samantha
    Reguilon, Irene
    Lynch, Charlotte
    Vedsted, Peter
    BRITISH JOURNAL OF CANCER, 2022, 127 (05) : 844 - 854
  • [5] An international consensus on actions to improve lung cancer survival: A clinical review by the international cancer benchmarking partnership (ICBP)
    Lynch, C.
    Harrison, S.
    Butler, J.
    Baldwin, D. R.
    Dawkins, P.
    van der Horst, J.
    Jakobsen, E.
    McAleese, J.
    McWilliams, A.
    Redmond, K.
    Swaminath, A.
    Finley, C.
    ANNALS OF ONCOLOGY, 2022, 33 : S119 - S120
  • [6] Explaining variation in cancer outcomes between eleven jurisdictions in the International Cancer Benchmarking Partnership: a primary care survey
    Rose, Peter
    Vedsted, Peter
    Rubin, Greg
    Harrison, Samantha
    Bomb, Martine
    Groves, Brad
    Hamilton, William
    EUROPEAN JOURNAL OF CANCER CARE, 2014, 23 : 30 - 31
  • [7] Diagnostic pathways for breast cancer in 10 International Cancer Benchmarking Partnership (ICBP) jurisdictions: an international comparative cohort study based on questionnaire and registry data
    Vedsted, Peter
    Weller, David
    Falborg, Alina Zalounina
    Jensen, Henry
    Kalsi, Jatinderpal
    Brewster, David
    Lin, Yulan
    Gavin, Anna
    Barisic, Andriana
    Grunfeld, Eva
    Lambe, Mats
    Malmberg, Martin
    Turner, Donna
    Harland, Elizabeth
    Hawryluk, Breann
    Law, Rebecca-Jane
    Neal, Richard D.
    White, Victoria
    Bergin, Rebecca
    Harrison, Samantha
    Menon, Usha
    BMJ OPEN, 2022, 12 (12):
  • [8] Understanding international variation in access to PET-CT for oncology diagnostics: An International Cancer Benchmarking Partnership (ICBP) study
    Lynch, Charlotte
    Reguilon, Irene
    Langer, Deanna
    Lane, Damon
    Wong, Wai-Lup
    McKiddie, Fergus
    Ross, Andrew
    Shack, Lorraine
    Win, Thida
    Marshall, Christopher
    Revheim, Mona-Elizabeth
    Danckert, Bolette
    Dizdarevic, Sabina
    McGivern, Canice
    Hazlett, Anne
    Louzado, Cheryl
    MacMillan, Mark
    Harrison, Sam
    BRITISH JOURNAL OF CANCER, 2019, 121 : 29 - 29
  • [9] Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP)
    Menon, Usha
    Vedsted, Peter
    Falborg, Alina Zalounina
    Jensen, Henry
    Harrison, Samantha
    Reguilon, Irene
    Barisic, Andriana
    Bergin, Rebecca J.
    Brewster, David H.
    Butler, John
    Brustugun, Odd Terje
    Bucher, Oliver
    Cairnduff, Victoria
    Gavin, Anna
    Grunfeld, Eva
    Harland, Elizabeth
    Kalsi, Jatinderpal
    Knudsen, Anne Kari
    Lambe, Mats
    Law, Rebecca-Jane
    Lin, Yulan
    Malmberg, Martin
    Turner, Donna
    Neal, Richard D.
    White, Victoria
    Weller, David
    BMJ OPEN, 2019, 9 (11):
  • [10] Exploring the link between cancer policies and cancer survival: a comparison of International Cancer Benchmarking Partnership countries
    Nolte, Ellen
    Morris, Melanie
    Landon, Susan
    McKee, Martin
    Seguin, Maureen
    Butler, John
    Lawler, Mark
    LANCET ONCOLOGY, 2022, 23 (11): : E502 - E514